Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Hann, Hie-Won L

< Back



Hie-Won L. Hann, MD

Contact Dr. Hann

32 South 10th Street
Main Building, Suite 480
Philadelphia, PA 19107

(215) 955-8900
(215) 503-2527 fax

Medical School

Seoul National University, Korea - 1961


Children's Hospital of Boston


Dana Farber Cancer Institute

Hospital Appointment

Thomas Jefferson University Hospital


Most Recent Peer-Reviewed Publications

  1. Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
  2. Vagaries of the host response in the development of hepatitis b-related hepatocellular carcinoma: A case series
  3. Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
  4. Persistent risk for hepatocellular carcinoma after more than a decade of successful hepatitis B virus suppression
  5. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
  6. Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case–Control Study
  7. Giving rituximab in patients with occult or resolved hepatitis B virus infection: Are the current guidelines good enough?
  8. Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection
  9. A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation
  10. Then and now: The progress in hepatitis B treatment over the past 20 years
  11. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy
  12. HBV-related health behaviors in a socio-cultural context: Perspectives from Khmers and Koreans
  13. Randomized comparison of Tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B
  14. Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma
  15. Correlates of Hepatitis B Virus Health-Related Behaviors of Korean Americans: A Situation-Specific Nursing Theory
  16. Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients
  17. Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort
  18. Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: A nested case-control analysis
  19. Erratum: Recognition and management of HBV infection in a social context (Journal of Cancer Education DOI: 10.1007/s13187-011-0203-5)
  20. Relative telomere length: A novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection
  21. The management of chronic hepatitis B in Asian Americans
  22. Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance
  23. Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated
  24. Recognition and management of HBV infection in a social context
  25. Analysis of GP73 in patients with HCC as a function of anti-cancer treatment